Page last updated: 2024-08-24

goralatide and Acute Disease

goralatide has been researched along with Acute Disease in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chopp, M; Ding, G; Jiang, Q; Li, L; Li, Q; Wei, M; Zhang, L; Zhang, Z1
Bignon, J; Gora-Tybor, J; Grzybowska-Izydorczyk, O; Liu, JM; Robak, T; Wdzieczak-Bakala, J1
Aksu, S; Beyazit, Y; Buyukasik, Y; Goker, H; Haznedaroglu, IC; Karakaya, J; Kekilli, M; Koca, E; Misirlioglu, M; Sayinalp, N; Tuncer, S1
Bordessoule, D; Comte, L; Frindel, E; Liozon, E; Pradelles, P; Praloran, V; Trimoreau, F; Volkov, L1
Dillingh, JH; Konings, AW; Wierenga, PK1
Kampinga, HH; Setroikromo, R; Vellenga, E; Wierenga, PK1

Other Studies

6 other study(ies) available for goralatide and Acute Disease

ArticleYear
MRI evaluation of BBB disruption after adjuvant AcSDKP treatment of stroke with tPA in rat.
    Neuroscience, 2014, Jun-20, Volume: 271

    Topics: Acute Disease; Animals; Blood-Brain Barrier; Brain; Capillary Permeability; Contrast Media; Disease Models, Animal; Drug Therapy, Combination; Fibrin; Fibrinolytic Agents; Gadolinium DTPA; Immunohistochemistry; Infarction, Middle Cerebral Artery; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Oligopeptides; Rats, Wistar; Tissue Plasminogen Activator

2014
Elevated plasma levels of the angiogenic tetrapeptide acetyl-ser-asp-lys-pro are found in some patients with hematologic malignancies.
    Leukemia & lymphoma, 2009, Volume: 50, Issue:12

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Angiogenesis Inducing Agents; Enzyme-Linked Immunosorbent Assay; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Male; Middle Aged; Oligopeptides

2009
Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia.
    Journal of the National Medical Association, 2007, Volume: 99, Issue:1

    Topics: Acute Disease; Angiotensins; Bone Marrow; Gene Expression Regulation, Leukemic; Leukemia, Myeloid; Oligopeptides; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System

2007
AcSDKP serum concentrations vary during chemotherapy in patients with acute myeloid leukaemia.
    British journal of haematology, 1995, Volume: 89, Issue:4

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Cell Division; Female; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid; Male; Middle Aged; Oligopeptides

1995
Reduction of heat-induced haemotoxicity in a hyperthermic purging protocol of murine acute myeloid leukaemic stem cells by AcSDKP.
    British journal of haematology, 1997, Volume: 99, Issue:3

    Topics: Acute Disease; Animals; Bone Marrow Purging; Female; Growth Inhibitors; Hematologic Diseases; Hematopoiesis; Hyperthermia, Induced; Leukemia, Myeloid; Mice; Oligopeptides; Tumor Cells, Cultured

1997
Purging of acute myeloid leukaemia cells from stem cell grafts by hyperthermia: enhancement of the therapeutic index by the tetrapeptide AcSDKP and the alkyl-lysophospholipid ET-18-OCH(3).
    British journal of haematology, 2000, Volume: 111, Issue:4

    Topics: Acute Disease; Animals; Bone Marrow Purging; Cell Cycle; Cell Death; Colony-Forming Units Assay; Hematopoietic Stem Cell Transplantation; Hot Temperature; Leukemia, Myeloid; Mice; Mice, Inbred CBA; Models, Animal; Neoplastic Stem Cells; Oligopeptides; Phospholipid Ethers; Stem Cells; Transplantation, Autologous

2000